| Identification | Back Directory | [Name]
9-Octadecenoic acid, (1R)-1-[17-[[O-α-D-galactopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl]oxy]-3-hydroxy-3-oxido-8,13-dioxo-2,4-dioxa-7,14-diaza-3-phosphaheptadec-1-yl]-1,2-ethanediyl ester, (9Z,9′Z)- | [CAS]
1821461-84-0 | [Synonyms]
| [Molecular Formula]
C70H126N3O26P | [MOL File]
1821461-84-0.mol | [Molecular Weight]
1456.73 |
| Hazard Information | Back Directory | [Uses]
AGI-134 is a fully synthetic alpha-Gal glycolipid. AGI-134 invokes CD8+ T cell-mediated immunity. AGI-134 induces tumor cell destruction and phagocytosis[1]. | [References]
[1] Irit Carmi LEVY, et al. Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors. WO2019229745A1. 2019. |
|
|